Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

Published:2022-03-14 Issue:11 Volume:128 Page:2073-2084
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Khan Amir Ishaq¹^ORCID,Psutka Sarah P.²^ORCID,Patil Dattatraya H.³^ORCID,Hong Gordon⁴,Williams Milton A.⁵,Bilen Mehmet A.⁶^ORCID,Sekhar Aarti⁷,Kissick Haydn T.³,Narayan Vikram M.³^ORCID,Joshi Shreyas S.³^ORCID,Ogan Kenneth³,Master Viraj A.³

Affiliation:

1. Department of Urology Yale University School of Medicine New Haven Connecticut

2. Department of Urology University of Washington School of Medicine Seattle Washington

3. Department of Urology Emory University School of Medicine Atlanta Georgia

4. Northeast Ohio Medical University Rootstown Ohio

5. Department of Urology University of Alabama at Birmingham School of Medicine Birmingham Alabama

6. Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta Georgia

7. Department of Radiology and Imaging Sciences Emory University School of Medicine Atlanta Georgia

Funder

Cook Family Foundation

Winston Churchill Foundation of the United States

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34174

Reference61 articles.

1. Epidemiology of Renal Cell Carcinoma

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013

4. Continued Increase in Incidence of Renal Cell Carcinoma, Especially in Young Patients and High Grade Disease: United States 2001 to 2010

5. Impact of geographic regions on overall survival in patients with metastatic renal cell carcinoma: results from an international clinical trials database;Fay AP;J Glob Oncol,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma;Clinical Genitourinary Cancer;2024-12

2. Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer;BJUI Compass;2024-06-13

3. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma;CA: A Cancer Journal for Clinicians;2024-04-03

4. Low muscle mass-to-fat ratio is an independent factor that predicts worse overall survival and complications in patients with colon cancer: a retrospective single-center cohort study;Annals of Surgical Treatment and Research;2024

5. Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma;Journal of Urologic Oncology;2023-11-30